Alliance Pharmaceutical Corporation

Alliance Pharmaceutical Corp is a pharmaceutical research and development company that focuses on developing scientific discoveries into medical products and licensing these products to multinational pharmaceutical companies in exchange for fixed payments and royalties. To date, the Company has developed three innovative products through initial clinical (human) trials, and is in, or is preparing to enter, pivotal clinical trials for these products. The products are OXYGENT-TM-, an intravascular oxygen carrier to temporarily augment oxygen delivery in surgical and other patients at risk of acute tissue hypoxia (oxygen deficiency); LIQUIVENT-Registered Trademark-, an intrapulmonary agent for use in reducing a patient's exposure to the harmful effects of conventional mechanical ventilation; and IMAGENT-Registered Trademark-, an intravenous contrast agent for enhancement of ultrasound images to assess cardic function, organ lesions and to detect blood flow abnormalities, which is licensed to Schering AG, Germany.

Contact Details: 3040 Science Park Road San Diego 92121 United States of America Tel: 619 558 4300 Fax: 619 558 3625 Email: corpcom@allp.com WWW: www.allp.com/

Recent Publications by Alliance Pharmaceutical Corporation:
Perfluorocarbon-based oxygen delivery. The basic properties of perfluorocarbons (PFCs) and PFC emulsions relevant...	22nd December, 2006	MRI Institute, University of California at San Diego and Alliance	Artif Cells Blood Substit Immobil Biotechnol. 2006;34(6):567-80. DOI Direct Link
Characterization of fluorocarbon-in-water emulsions with added triglyceride. Fluorocarbon-in-water emulsions are being explored clinically as synthetic...	11th March, 2006	Alliance Pharmaceutical Corp., 6175 Lusk Boulevard, San Diego, California	Langmuir. 2004 Aug 31;20(18):7430-5. DOI Direct Link
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics. Parenteral administration of immunoglobulins (Ig) for prevention or...	15th January, 2005	Department of Immunology, Alliance Pharmaceutical Corp. San Diego, CA	J Control Release. 2004 Mar 24;95(3):489-500. DOI Direct Link
Oxygen therapeutics ("blood substitutes") where are they, and what can we expect? Fluorocarbon-in-water emulsions are being explored clinically as synthetic...	20th July, 2004	Alliance Pharmaceutical Corp., San Diego, California, 92121, USA.	Adv Exp Med Biol. 2003;540:207-13.
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. Influenza viruses are among the most significant human pathogens,...	7th April, 2004	Department of Immunology, Alliance Pharmaceutical Corp., San Diego, CA,	Vaccine. 2003 Jun 20;21(21-22):2805-12.
→View more Alliance Pharmaceutical Corporation research publications.

BioNews Results for Alliance Pharmaceutical Corporation:
Acorn Award winners	PrimaryCare Today:  Nov 12 2009 10:56AM Matching: alliance pharmaceutical
Endorsement rules change for clopidogrel prescriptions	PJ Online:  Nov 12 2009 1:37PM Matching: alliance pharmaceutical
Endorsement rules change for clopidogrel prescriptions	PJ Online:  Nov 12 2009 1:37PM Matching: alliance pharmaceutical
DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix	Bioresearch Online:  Nov 9 2009 7:05AM Matching: alliance pharmaceutical
DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix	Pharmaceutical Online:  Nov 9 2009 6:13AM Matching: alliance pharmaceutical
Promote your company here: BioNewsCast - Press Release Distribution	→View more Alliance Pharmaceutical Corporation news.

Alliance Pharmaceutical Corporation Patents:
US Patent No.	Title
5702881	Method and solution for organ preservation comprising retinal-derived growth factor, cyclodextrin, mucopolysaccharide and fluorocarbon
5847206	Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications
5853003	Treatment and diagnosis of respiratory disorders using fluorocarbon liquids
5861175	Use of fluorocarbons for diagnosis and treatment of articular disorders
5865784	Method of hemodilution facilitated by monitoring oxygenation status
→View more Alliance Pharmaceutical Corporation patents.

Alliance Pharmaceutical Corporation (ALLP.OB) Financial information Links from Barchart
ALLP.OB Quote from from Barchart.com
ALLP.OB Chart from from Barchart.com
ALLP.OB Profile from from Barchart.com
ALLP.OB Opinion from from Barchart.com
→View more Alliance Pharmaceutical Corporation finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 18 individuals from Alliance Pharmaceutical Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1223 times since April 2007, the link to the organisation's website has been followed 178 times

Recent Search Terms used to find this page: MRI Institute University of California at San Diego and Alliance Pharmaceutical Corp. San Diego CA USA | alliance pharmaceuticals san diego | Oxygen therapeutics blood substitutes where are they | Oxygen therapeutics blood substitutes where are they | Alliance Pharmaceutical Corp | LiquiVent by Alliance Pharmaceutical Corporation. | Alliance Pharmaceutical Corp | Alliance Pharmaceutical Corp. 2009 news | alliance pharmaceutical corp. allp.ob | Alliance Pharmaceutical Corp | .

Search for more companies in San Diego

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Alliance Pharmaceutical Corporation